Jeremy Veenstra-VanderWeele uses molecular and translational neuroscience research tools in the pursuit of new treatments for autism.
Jeremy Veenstra-VanderWeele
From this contributor
Why serotonin medications may yet help children with autism
A class of medications used to treat obsessive-compulsive disorder seems to ease compulsive behaviors in adults with autism. Why can't we tell if these medications work similarly in children with the condition?
Why serotonin medications may yet help children with autism
By
Jeremy Veenstra-VanderWeele
28 January 2020 | 5 min read
How to evaluate new medications for autism
There are no available medications for treating autism’s core symptoms, but there are several candidates in clinical trials. Jeremy Veenstra-VanderWeele describes the factors researchers must take into account when developing drugs for the disorder.
How to evaluate new medications for autism
By
Jeremy Veenstra-VanderWeele
10 June 2014 | 8 min read
Explore more from The Transmitter
In memoriam: Howard Fields, pain research pioneer
Over six decades, Fields mapped out the circuits of both pain and addiction.
In memoriam: Howard Fields, pain research pioneer
Over six decades, Fields mapped out the circuits of both pain and addiction.
By
Natalia Mesa
22 May 2026 | 7 min read
Still no proof for facilitated spelling methods
A systematic review into whether the “rapid prompting method” or “spelling to communicate” can help autistic people express themselves comes up empty yet again.
Still no proof for facilitated spelling methods
A systematic review into whether the “rapid prompting method” or “spelling to communicate” can help autistic people express themselves comes up empty yet again.
By
Brendan Borrell
21 May 2026 | 6 min read
Oregon primate center scientists fight proposed sanctuary transition
A group of employees has launched a series of campaigns to advocate for their work and argue against the center’s potential transition to an animal sanctuary.
Oregon primate center scientists fight proposed sanctuary transition
A group of employees has launched a series of campaigns to advocate for their work and argue against the center’s potential transition to an animal sanctuary.
By
Calli McMurray
21 May 2026 | 6 min read